To get deals in your inbox each morning, sign up for our Term Sheet newsletter
Venture Capital DealsChase Pharmaceuticals Corp., a Washington, D.C.-based drug development company focused on Alzheimer-type dementia, has raised $21 million in Series B funding. New Rhein Healthcare Investors led the round, and was joined by Edmond de Rothschild Investment Partners, Cipla Ventures and return backer Brain Trust Accelerator Fund. www.chasepharmaceuticals.com
Pure Life Renal, a Hollywood, Fla.-based provider of kidney dialysis MORE